[Alternative treatment for acute asthmatic crisis]

Area of Science:

• Pulmonology
• Pharmacology

Background:

• Acute asthma exacerbations require prompt and effective bronchodilator therapy.
• Salbutamol is a common short-acting beta-agonist used for asthma relief.

Purpose of the Study:

• To compare the efficacy and safety of nebulized salbutamol versus subcutaneous salbutamol in treating acute asthma episodes.

Main Methods:

• A double-blind study involving 20 patients with acute asthma.
• Randomized treatment with either nebulized salbutamol (5 mg) or subcutaneous salbutamol (0.5 mg).
• Assessed clinical condition, bronchial dilation, and side effects.

Main Results:

• No significant difference in clinical condition improvement between groups.
• Both treatments achieved similar levels of significant bronchial dilation.
• Subcutaneous salbutamol caused a significant increase in heart rate; other side effects were minor and comparable.

Conclusions:

• Nebulized salbutamol is an effective treatment for acute asthma in selected patients.
• Nebulized administration offers comparable efficacy to subcutaneous injections with potentially fewer cardiovascular side effects.